-
Roche to acquire hepatitis C specialist AnadysRoche has agreed to purchase US-based Anadys Pharmaceuticals, a specialist in hepatitis C treatments, for around $230m in cash. Roche's attraction to Anadys is focused on the company's ANA598 compoun2011/10/19
-
Bayer and Onyx restructure oncology collaborationBayer HealthCare and Onyx Pharmaceuticals have restructured their oncology partnership relating to the medication Nexavar and late-stage compound regorafenib. As per the revised agreement, Nexavar wi2011/10/18
-
Roche acquires HCV manufacturerSwiss drug company Roche has entered into a definite merger agreement to acquire Anadys Pharmaceuticals for $230 million. The company said on Monday that it will buy Anadys, a developer of oral and s2011/10/18
-
Scientists conclude pesticide contamination as a major problem in EuropeList of chemicals to be monitored should be updated immediately Pesticides are a bigger problem than had long been assumed. This is the conclusion of a study in which scientists analysed data on 5002011/10/17
-
GlycoMimetics and Pfizer to further develop GMI-1070GlycoMimetics has entered into an exclusive worldwide licensing agreement with Pfizer for the advancement of GlycoMimetics' investigational compound, GMI-1070. GMI-1070, a pan-selectin inhibitor, is2011/10/17
-
Achievement of pre-clinical milestone triggers $4M payment from GSK to EpizymeEpizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer patients, today announced the achievement of pre-clinical milestones in its a2011/10/17
-
India to tighten scrutiny over foreign pharmaceutical takeoversIndia will tighten scrutiny over foreign takeovers of Indian pharmaceutical firms as part of discussions meant to ease concerns over the domestic drug industry in the country. From now, "brownfield2011/10/14
-
FDA clears Merck type 2 diabetes medicationThe US Food and Drug Administration (FDA) has approved Merck's Juvisync, a once-daily therapy for type 2 diabetes that combines glucose-lowering medication sitagliptin, the active component of Januvia2011/10/14
-
Meet Roquette at CPHI FrankfurtRoquette is a long-established supplier of actives and excipients to the pharmaceutical and cosmetics industries. Our new slogan "Simply formulate your wishes" points to the many services we offer and2011/10/14
-
Vitamin D plays an essential role in the body's fight against TBNot just important for building strong bones, an international team of scientists has found that vitamin D also plays an essential role in the body's fight against infections such as tuberculosis.2011/10/14